Frontline Ltd (FRO) Jumps 5.54% on February 17

Equities Staff |

Frontline Ltd (FRO) was among the biggest gainers on the Russell 2000 for Wednesday February 17 as the stock popped 5.54% to $9.25, representing a gain of $0.485 per share. Some 762,517 shares traded hands on 4,095 trades, compared with an average daily volume of 566,657 shares out of a total float of 156.39 million. The stock opened at $8.87 and traded with an intraday range of $9.40 to $8.85.

After today's gains, Frontline Ltd reached a market cap of $1.45 billion. Frontline Ltd has had a trading range between $17.05 and $7.78 over the last year, and it had a 50-day SMA of $12.17 and a 200-day SMA of $13.38.

The stock has a P/E Ratio of 5.5.

Frontline Ltd is an international shipping company. The Company operates in the tanker market as an international provider of seaborne transportation of crude oil.

Frontline Ltd is based out of Hamilton, and has some 118 employees. Its CEO is John Fredriksen.

For a complete fundamental analysis analysis of Frontline Ltd, check out Equities.com’s Stock Valuation Analysis report for FRO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…